{"organizations": [], "uuid": "dc823e55cb6c383a727b4a2fad7af15aca02c9d0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/05/08/the-associated-press-corcept-1q-earnings-snapshot.html", "country": "US", "domain_rank": 767, "title": "Corcept: 1Q Earnings Snapshot", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-09T02:55:00.000+03:00", "replies_count": 0, "uuid": "dc823e55cb6c383a727b4a2fad7af15aca02c9d0"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/05/08/the-associated-press-corcept-1q-earnings-snapshot.html", "ord_in_thread": 0, "title": "Corcept: 1Q Earnings Snapshot", "locations": [], "entities": {"persons": [{"name": "corcept", "sentiment": "none"}], "locations": [{"name": "menlo park", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "menlo park", "sentiment": "none"}], "organizations": [{"name": "cort", "sentiment": "negative"}, {"name": "corcept therapeutics inc.", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "MENLO PARK, Calif. (AP) _ Corcept Therapeutics Inc. (CORT) on Tuesday reported first-quarter profit of $17.3 million.\nThe Menlo Park, California-based company said it had profit of 14 cents per share. Earnings, adjusted for stock option expense and non-recurring costs, were 19 cents per share.\nThe drug developer posted revenue of $57.7 million in the period, which beat Street forecasts. Three analysts surveyed by Zacks expected $56 million.\nCorcept expects full-year revenue in the range of $275 million to $300 million.\nCorcept shares have dropped roughly 4 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $17.36, an increase of 87 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on CORT at https://www.zacks.com/ap/CORT", "external_links": ["https://www.zacks.com/ap/CORT", "http://automatedinsights.com/ap"], "published": "2018-05-09T02:55:00.000+03:00", "crawled": "2018-05-09T02:22:39.003+03:00", "highlightTitle": ""}